Clinical Trial Update: Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how CYP2C19 genetic variants influence the pharmacokinetics and pharmacodynamics of omeprazole in gastric ulcer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Stomach Ulcer | Phase 1 | Status: COMPLETED